Peripheral Cholangiocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-07-01
Clinical Trial Results: Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) [Phase 2]
Phase 2 trial evaluating hepatic arterial infusion with floxuridine and dexamethasone plus systemic gemcitabine and oxaliplatin in unresecta…
CLINICAL_TRIALS trial_result · 2025-03-19
Clinical Trial Update: Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) [Phase 2]
Phase 2 clinical trial evaluating hepatic arterial infusion with floxuridine and dexamethasone in combination with systemic gemcitabine and …